MORE ROBERT J 4
4 · Vir Biotechnology, Inc. · Filed Jun 2, 2025
Insider Transaction Report
Form 4
MORE ROBERT J
Director
Transactions
- Award
Common Stock
2025-05-30+8,000→ 54,683 total - Award
Stock Option (Right to Buy)
2025-05-30+16,000→ 16,000 totalExercise: $4.94From: 2026-05-30Exp: 2035-05-29→ Common Stock (16,000 underlying)
Holdings
- 495,890(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- [F2]The RSUs will vest in full on May 30, 2026.
- [F3]The shares are held by Alta Partners NextGen Fund I, L.P. (APNG 1). The reporting person is a managing director of Alta Partners NextGen Fund I Management, LLC, which is the general partner of APNG 1. As such, the reporting person may be deemed to beneficially own the shares held by APNG 1. The reporting person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.
- [F4]The shares subject to the stock option will vest and become exercisable in full on May 30, 2026.